[1] World Health Organisation (WHO) (2019) Corona Virus Disease 2019. (COVID19): Situation Report-84. WHO, Geneva.
[2] Huang, C., Wang, Y., Li, X., et al. (2020) Clinical Feature of Patients with 2019 Novel Corona Virus in Wuhan, China. The Lancet, 395, 497-506.
https://doi.org/10.1016/S0140-6736(20)30183-5
[3] Chen, N., Zhou, M., Dong, X., et al. (2020) Epidemiological and Clinical Characteristic of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. The Lancet, 395, 507-513.
https://doi.org/10.1016/S0140-6736(20)30211-7
[4] Wang, D., Hu, B., et al. (2020) Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Corona Virus Infected Pneumonia in Wuhan, China. JAMA, 323, 1061-1069.
https://doi.org/10.1001/jama.2020.1585
[5] Kui, L., Fang, Y.Y., Deng, Y., et al. (2020) Clinical Characteristics of Novel Corona Virus Cases in Tertiary Hospitals in Hubei Province. Chinese Medical Journal, 133, 1025-1031.
[6] Chen, X.P., et al. (2020) Hypertension and Diabetes Delay the Viral Clearance in COVID19 Patients.
[7] Carlos, W.G., Dela Cruz, C.S., Cao, B., Pasnick, S. and Jamil, S. (2020) Novel Wuhan (2019-nCoV) Coronavirus. American Journal of Respiratory and Critical Care Medicine, 201, P7-P8.
https://doi.org/10.1164/rccm.2014P7
[8] Rothe Camilla, S.M., Peter, S., Gisela, B., et al. (2020) Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. The New England Journal of Medicine, 382, 970-971.
https://doi.org/10.1056/NEJMc2001468
[9] Li, J., Niu, P.H., Yang, B., et al. (2020) Genomic Characterization and Epidemiology of 2019 Novel Coronavirus Implications for Virus Origins and Receptor Bindings. The Lancet, 395, 565-574.
https://doi.org/10.1016/S0140-6736(20)30251-8
[10] Lo, L.L., Lio, C.F., Cheong, H.H., et al. (2020) Evaluation of SARS-CoV-2 RNA Shedding in Clinical Specimens and Clinical Characteristics of 10 Patients with COVID 19 in Macau. International Journal of Biological Sciences, 16, 1698-1707.
https://doi.org/10.7150/ijbs.45357
[11] Liu, Y., Yan, L.M., Wan, L., et al. (2020) Viral Dynamics in Mild and Severe Cases of COVID19. The Lancet Infectious Diseases, 20, 656-657.
[12] Ling, Y., Yan, L.M., Wan, L., et al. (2020) Persistence and Clearance of Viral RNA in 2019 Novel Corona Virus Disease Rehabilitation Patients. Chinese Medical Journal, 133, 1039-1043.
[13] Fang, L.K. and Roth, G.M. (2020) Are Patients with Hypertension and Diabetes Mellitus at Increased Risk for COVID19 Infections? The Lancet Respiratory Medicine, 8, e21.
https://doi.org/10.1016/S2213-2600(20)30116-8
[14] Li, X.C., Zhang, J. and Zhuo, J.L. (2017) The Vasoprotective Axes of the Rennin-Angiotensin System: Physiological Relevance and Therapeutic Implications in Cardiovascular, Hypertensive and Kidney Disease. Pharmacological Research, 125, 21-38.
https://doi.org/10.1016/j.phrs.2017.06.005
[15] D’Antiga, L. (2020) Coronaviruses and Immunosuppressed Patients. The Facts during the Third Epidemic. Liver Transplantation, 26, 832-834.
https://doi.org/10.1002/lt.25756